RadNet Inc. (RDNT)
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
Do Options Traders Know Something About RadNet Stock We Don't?
Investors need to pay close attention to RDNT stock based on the movements in the options market lately.
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet Q1 Earnings Call Highlights
RadNet NASDAQ: RDNT reported record first-quarter 2026 revenue and adjusted EBITDA, with management saying demand for advanced imaging and the growing contribution of its Digital Health business helped offset severe winter weather disruptions on the East Coast.
Will RadNet (RDNT) Report Negative Earnings Next Week? What You Should Know
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
RadNet's Pullback Offers Upside With Outpatient Imaging And AI
RadNet combines a scaled outpatient imaging platform with DeepHealth. This is their AI-enabled radiology software segment that adds growth optionality. RDNT's core imaging demand also remains strong, helped by outpatient site-of-care trends, but their acquisitions and hospital joint ventures are part of the story. Management reported record Q4 2025 revenue, while underlying organic growth suggests the base imaging business is still healthy.
RadNet, Inc. (RDNT) GLEAMER SAS - M&A Call Transcript
RadNet, Inc. (RDNT) GLEAMER SAS - M&A Call Transcript
RadNet, Inc. (RDNT) Q4 2025 Earnings Call Transcript
RadNet, Inc. (RDNT) Q4 2025 Earnings Call Transcript
Compared to Estimates, RadNet (RDNT) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Exploring Analyst Estimates for RadNet (RDNT) Q4 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
RadNet, Inc. (RDNT) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
RadNet, Inc. (RDNT) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript
